Document ID: chunk:federal_register_of_legislation:F2025C00158:clause:3_1:p5
Version: federal_register_of_legislation:F2025C00158
Segment Type: clause
Provision Reference: sch 3 cl 1 (pt 5/6)
Character Range: 9447605–9450630

670 339 867
WM    MEDISON PHARMA AUSTRALIA PTY LIMITED            19 659 723 403
WZ    Bridgewest Perth Pharma Pty Ltd                 21 663 385 411
XC    Southern Cross Pharma Pty Ltd                   47 094 447 677
XE    ACCELAGEN PTY LTD                               11 142 888 766
XH    MS Health Pty Ltd                               33 155 182 586
XI    Alexion Pharmaceuticals Australasia Pty Ltd     59 132 343 036
XN    Southern XP Pty Ltd                             34 639 505 481
XO    Echo Therapeutics Pty Ltd                       92 628 298 699
XT    Arrotex Pharmaceuticals Pty Ltd                 30 605 552 234
XW    Arrotex Pharmaceuticals Pty Ltd                 30 605 552 234
XY    MAXX PHARMA PTY LTD                             33 629 622 224
YG    EUGIA PHARMA (AUSTRALIA) PTY LTD                57 656 083 028
YN    Mayne Pharma International Pty Ltd              88 007 870 984
YO    The Trustee for ORSPEC PHARMA UNIT TRUST        15 634 980 417
YT    Mayne Products Pty Ltd                          59 140 866 379
ZB    Specialised Therapeutics Pm Pty Ltd             50 617 311 083
ZE    Seekwell Pty Ltd                                91 624 401 618
ZL    Specialised Therapeutics Pharma Pty Ltd         77 609 261 430
ZO    Swedish Orphan Biovitrum Pty Ltd                14 645 396 532
ZS    Strides Pharma Science Pty Ltd                  44 635 036 734
ZU    Seekwell Pty Ltd                                91 624 401 618

National Health (Listing of Pharmaceutical Benefits) Instrument 2024

PB 26 of 2024
made under sections 84AF, 84AK, 85, 85A and 88 of the

National Health Act 1953

Compilation No. 10

Compilation date: 1 February 2025

                Includes amendments: F2025L00062

This compilation is in 10 volumes

Volume 1: sections 1–24 and Schedule 1 (Part 1: A–C)
Volume 2: Schedule 1 (Part 1: D–K)
Volume 3: Schedule 1 (Part 1: L–P)
Volume 4: Schedule 1 (Part 1: Q–Z, Part 2), Schedules 2 and 3
Volume 5: Schedule 4 (Part 1: C4076–C9993)
Volume 6: Schedule 4 (Part 1: C10020–C12999)
Volume 7: Schedule 4 (Part 1: C13006–C13925)
Volume 8: Schedule 4 (Part 1: C13927–C14567)
Volume 9: Schedule 4 (Part 1: C14568–C16290, Part 2)
Volume 10: Schedules 5, 6 and Endnotes

Each volume has its own contents

About this compilation

This compilation

This is a compilation of the National Health (Listing of Pharmaceutical Benefits) Instrument 2024 that shows the text of the law as amended and in force on 1 February 2025 (the compilation date).

The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.

Uncommenced amendments

The effect of uncommenced amendments is not shown in the text of the compiled law. Any uncommenced amendments affecting the law are accessible on the Register (www.legislation.gov.au). The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. For more information on any uncommenced